David John Mott
David John Mott
Office of Health Economics
Verifierad e-postadress på ohe.org - Startsida
Titel
Citeras av
Citeras av
År
Incorporating quantitative patient preference data into healthcare decision making processes: is HTA falling behind?
DJ Mott
The Patient-Patient-Centered Outcomes Research 11 (3), 249-252, 2018
332018
Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy
DJ Mott, M Najafzadeh
Expert review of pharmacoeconomics & outcomes research 16 (1), 33-39, 2016
182016
Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
DJ Mott, KK Shah, JM Ramos-Goñi, NJ Devlin, O Rivero-Arias
Medical Decision Making 41 (5), 584-596, 2021
122021
Challenges in valuing temporary health states for economic evaluation: a review of empirical applications of the chained time trade-off method
J Stoniute, DJ Mott, J Shen
Value in Health 21 (5), 605-611, 2018
92018
Conducting a time trade-off study alongside a clinical trial: a case study and recommendations
J Shen, S Hill, D Mott, M Breckons, L Vale, R Pickard
PharmacoEconomics-open 3 (1), 5-20, 2019
62019
Reporting quality of marginal rates of substitution in discrete choice experiments that elicit patient preferences
DJ Mott, N Chami, T Tervonen
Value in Health 23 (8), 979-984, 2020
42020
A multinational European study of patient preferences for novel diagnostics to manage antimicrobial resistance
DJ Mott, G Hampson, MJ Llewelyn, J Mestre-Ferrandiz, MM Hopkins
Applied health economics and health policy 18 (1), 69-79, 2020
32020
Public preferences for health gains and cures: a discrete choice experiment
G Hampson, D Mott, N Devlin, K Shah
Office of Health Economics, London, 2019
32019
Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?
P Cubi-Molla, D Mott, N Henderson, B Zamora, M Grobler, M Garau
Office of Health Economics Research Papers, 2021
12021
PCN382-quality of life in long-term cancer survivors: Implications for future health technology assessments in oncology
P Cubi-Molla, DJ Mott, K Shah, M Herdman, Y Summers, C Tsuchiya, ...
Value in Health 21, S79, 2018
12018
How is Quality of Life Measured for Health Technology Assessments?
D Mott, G Kumar, C Sampson, M Garau
Briefings, 2021
2021
Impact of Including Carer Information in Time Trade-Off Tasks: Results from a Pilot Study
DJ Mott, I Leslie, KK Shah, J Rowell, N Scheuer
PharmacoEconomics - Open, 2021
2021
A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE
H Payne, A Robinson, B Rappe, S Hilman, U De Giorgi, S Joniau, ...
International Journal of Cancer, 2021
2021
What aspects of health and quality of life are important to people?
K Shah, B Mulhern, M Janssen, P Cubi-Molla, D Mott
QUALITY OF LIFE RESEARCH 28, S138-S138, 2019
2019
Comparing Alternative Choice Models of Heterogeneity in the Valuation of Children’s Health
O Rivero-Arias, D Mott, K Shah, JM Ramos-Goñi, N Devlin
2019 World Congress on Health Economics, 2019
2019
How do preferences for public health interventions differ? a case study using a weight loss maintenance intervention
DJ Mott
Newcastle University, 2018
2018
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–16